Related Experiment Videos

Inhibitory effect of melittin on Na+,K+-ATPase from guinea pig myocardial mitochondria

S Yang1, X M Zhang, M H Jiang

  • 1Department of Pharmacology, School of Pharmacy, Fudan University, Shanghai 200032, China. mhjiang@shmu.edu.cn

Acta Pharmacologica Sinica
|December 18, 2001
PubMed
Abstract

Insights

Melittin (Mel) potently inhibits Na+,K+-ATPase in guinea pig heart mitochondria. This enzyme inhibition is concentration-dependent and competitive with potassium (K+).

Area of Science:

  • Biochemistry
  • Cardiology
  • Mitochondrial Function

Background:

  • Na+,K+-ATPase is crucial for maintaining cellular ion gradients and cardiac function.
  • Melittin, a peptide from bee venom, has known biological activities.
  • Understanding melittin's effects on key cardiac enzymes is important for potential therapeutic or toxicological insights.

Purpose of the Study:

  • To elucidate the impact of melittin on Na+,K+-ATPase activity in guinea pig myocardial mitochondria.
  • To characterize the kinetic mechanism by which melittin interacts with Na+,K+-ATPase.

Main Methods:

  • Colorimetric assays were employed to quantify Na+,K+-ATPase activity.
  • Enzyme kinetics were studied to determine the mode of inhibition by melittin.

Main Results:

  • Melittin demonstrated potent inhibition of Na+,K+-ATPase in a dose- and time-dependent manner.
  • The half-maximal inhibitory concentration (IC50) was determined to be 2.60 micromol/L.
  • Kinetic analysis revealed that melittin's inhibition is competitive with potassium (K+) but not with sodium (Na+) or ATP.

Conclusions:

  • Melittin acts as a potent inhibitor of Na+,K+-ATPase in cardiac mitochondria.
  • The inhibitory mechanism likely involves binding to the potassium-binding site of the enzyme.
  • These findings suggest a specific molecular interaction that could influence mitochondrial function and cardiac electrophysiology.

Related Concept Videos